Ascent Group, LLC Bio Techne Corp Transaction History

Ascent Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 16, 2023	BUY	$80.67 - $352.29 $139,075 - $607,347	1,724 Added 214.96%	2,526 $209,000
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $24,298 - $33,699	86 Added 12.01%	802 $238,000
Q2 2022 Aug 05, 2022	BUY	$322.67 - $449.65 $15,810 - $22,032	49 Added 7.35%	716 $276,000
Q1 2022 May 10, 2022	BUY	$353.85 - $487.79 $10,261 - $14,145	29 Added 4.55%	667 $289,000
Q4 2021 Mar 01, 2022	BUY	$456.15 - $525.06 $291,023 - $334,988	638 New	638 $234,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.96B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Ascent Group, LLC with notifications on news.